CKD Flashcards
Which of the following is considered a newly recognized risk factor for chronic kidney disease (CKD)?
A. Diabetes mellitus
B. Hypertension
C. A past episode of recovered acute kidney injury (AKI)
D. Obesity
C
Most recently identified risk factors for which there is now a consensus include a past episode of apparently recovered acute kidney injury (AKI), tobacco use, and many forms of apparently resolved childhood and adolescent kidney disease.
Which genetic factor is linked to a higher incidence of nondiabetic CKD in individuals of West African ancestry?
A. HLA-B27
B. APOL1 gene
C. BRCA1 gene
D. GFR1 mutation
B
Which of the following methods is currently recommended for measuring albuminuria in patients at risk for CKD?
A. 24-hour urine collection
B. Serum albumin concentration
C. Urinary albumin-to-creatinine ratio (UACR) from spot first-morning urine samples
D. Dipstick test for proteinuria
C
Which of the following statements about CKD staging using estimated glomerular filtration rate (eGFR) is correct?
A. Serum creatinine levels are sufficient for staging CKD.
B. eGFR is only calculated in patients with proteinuria.
C. eGFR equations are only valid when serum creatinine is stable.
D. Race adjustment in eGFR equations has no societal implications.
C
Which GFR level corresponds to stage 5 CKD?
A. >90 mL/min per 1.73 m²
B. 60-89 mL/min per 1.73 m²
C. 30-59 mL/min per 1.73 m²
D. <15 mL/min per 1.73 m²
D
Which of the following statements best describes the recommended screening for CKD in the general population?
A. Screen all adults regardless of risk factors.
B. Screen only patients with a family history of CKD.
C. Screen individuals with recognized CKD risk factors every 2 years.
D. Screen only elderly patients over the age of 70.
C
The most frequent cause of CKD in North America and Europe is ____
diabetic nephropathy, most often secondary to type 2 diabetes mellitus.
The benefits of the RAS inhibitors in ameliorating hyperfiltration and progression of CKD often favor their cautious and judicious use with very close monitoring of plasma potassium concentration.
T
Diuretic resistance with intractable edema and hypertension in advanced CKD may serve as an indication to initiate dialysis.
T
decline in GFR is not necessarily accompanied by a parallel decline in urinary potassium excretion
T
Type of acidosis seen in early stages of CKD
Non anion gap metabolic acidosis
_____promote urinary potassium excretion, whereas potassium-binding resins, such as calcium resonium, sodium polystyrene, or patiromer, can promote potassium loss through the _____
Kaliuretic diuretics
GI tract
Which of the following is a major driver of secondary hyperparathyroidism in CKD?
A) Increased renal calcitriol production
B) Phosphate retention
C) Elevated ionized calcium levels
D) Increased urinary calcium excretion
B
What type of bone disease is primarily associated with secondary hyperparathyroidism in CKD?
A) Osteomalacia
B) Osteitis fibrosa cystica
C) Adynamic bone disease
D) Brown tumors
B
Secondary hyperparathyroidism causes high-turnover bone disease, characterized by osteitis fibrosa cystica with abnormal osteoid and marrow fibrosis.
C. Low. bone turnover
Which laboratory abnormality is typically seen early in CKD and contributes to the development of secondary hyperparathyroidism?
A) Hypercalcemia
B) Hypophosphatemia
C) Elevated FGF-23 levels
D) Increased calcitriol levels
C
Which bone disease in CKD is associated with low or normal PTH levels and reduced bone turnover?
A) Osteitis fibrosa cystica
B) Adynamic bone disease
C) Osteomalacia
D) Paget’s disease
B
What is the primary cause of osteomalacia in CKD?
A) Hypocalcemia due to hyperphosphatemia
B) Reduced production of 1,25(OH)2D3 (calcitriol)
C) Elevated PTH levels
D) Use of calcimimetic agents
B
____ is a devastating condition seen almost exclusively in patients with advanced CKD.
Calciphylaxis
Medication considered as a risk factor for calciphylaxis
Warfarin
The optimal management of secondary hyperparathyroidism and osteitis fibrosa is _____.
prevention
Current National Kidney Foundation Kidney Disease Outcomes Quality Initiative guidelines recommend a target PTH level between _____ times the upper limit of normal,
2 and 9
This class of drug, which includes _____ produces a dose-dependent reduction in PTH and plasma calcium concentration in some patients.
cinacalcet and etecalcetide
_____are the most common complications of CKD.
Hypertension and left ventricular hypertroph
______should be the first line of therapy
Salt restriction
______ is an absolute indication for the urgent initiation of dialysis or for intensification of the dialysis prescription in those already receiving dialysis.
Uremic pericarditis
A normocytic, normochromic anemia is observed as early as stage ___CKD and is almost universal by stage ____
3
4.
ECG monitoring studies have s gested that _____are the principal causes of sudden cardiac death in dialysis patients.
asystole and bradyarrhythmias